Patent details

EP3083677 Title: NOVEL EUKARYOTIC CELLS AND METHODS FOR RECOMBINANTLY EXPRESSING A PRODUCT OF INTEREST

Basic Information

Publication number:
EP3083677
PCT Application Number:
IB2014067076
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP148218605
PCT Publication Number:
WO2015092737
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NOVEL EUKARYOTIC CELLS AND METHODS FOR RECOMBINANTLY EXPRESSING A PRODUCT OF INTEREST
French Title of Invention:
NOUVELLES CELLULES EUCARYOTES ET PROCÉDÉS D'EXPRESSION DE MANIÈRE RECOMBINANTE D'UN PRODUIT D'INTÉRÊT
German Title of Invention:
NEUARTIGE EUKARYOTISCHE ZELLEN UND VERFAHREN ZUR REKOMBINANTEN EXPRESSION EINES PRODUKTS VON INTERESSE
SPC Number:

Dates

Filing date:
18/12/2014
Grant date:
28/08/2019
EP Publication Date:
26/10/2016
PCT Publication Date:
25/06/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
28/08/2019
EP B1 Publication Date:
28/08/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
18/12/2019
Expiration date:
18/12/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
21/08/2019
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:
RITTER, Anett
Address:
Switzerland (CH)

2

Name:
LAUX, Holger
Address:
Switzerland (CH)

3

Name:
JOSTOCK, Thomas
Address:
Switzerland (CH)

Priority

Priority Number:
201361919340 P
Priority Date:
20/12/2013
Priority Country:
United States (US)

Classification

IPC classification:
C07K 14/47; C12N 15/113;

Publication

European Patent Bulletin

1

Issue number:
201935
Publication date:
28/08/2019
Description:
Grant (B1)

2

Issue number:
201940
Publication date:
02/10/2019
Description:
Application number/publication number of the divisional application (Art. 76) changed

3

Issue number:
202146
Publication date:
17/11/2021
Description:
Termination of the opposition

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages